Keep informed about the latest topics in global health.
#VaccinesWork
FOCUS AREAS African Vaccine Manufacturing Accelerator (AVMA) Zero-Dose Child Gavi Secretariat and leadership Progress report Partners Our Board
CAREERS Current vacancies Internship programme RFPs and consulting
Contact us ISO certification Phishing and fraud
SUPPORTED COUNTRIESDetailed information on each Gavi-eligible countryExplore our Country Hub
FOR COUNTRIES
Apply for support
Gavi 5.0 Ceilings by country and support type
OUR RESULTS
Evaluation studies
Facts and figures
Progress reports
COVID-19
The Global Vaccine Impact Conference explained
Read article
KEY AREAS
Donor profiles
Matching Fund
Pneumococcal AMC
FEATURED STORY
Everything you need to know about Gavi's incoming CEO, Dr Sania Nishtar
KEY PUBLICATION
The 2023 Mid-Term Review Report
PROGRESS REPORT
Access all of the press releases and statements related to the work of the Vaccine Alliance
24 October 2019
Gavi celebrates global eradication of wild poliovirus type 3
18 October 2019
Kenya introduces cervical cancer vaccine nationally
10 October 2019
Gavi congratulates Global Fund on successful replenishment
24 September 2019
Prime Minister of Bangladesh receives 2019 Vaccine Hero Award
19 September 2019
Gavi at the UNGA: People, planet and prosperity
10 September 2019
Gavi receives the 2019 Lasker~Bloomberg Public Service Award
30 August 2019
Gavi sets ambitious goal to immunise 300 million people by 2025, leaving no one behind
28 August 2019
Gavi and Japanese growth equity fund collaborate to support innovative startups for immunisation
New Gavi impact figures released: 66 million immunised and 1.7 million deaths averted in 2018
18 July 2019
IFFIm issues NOK600 million Vaccine Bonds
27 June 2019
New 2021-2025 high level strategy to leave no-one behind with immunisation approved by Gavi Board
11 June 2019
New management training for immunisation leaders kicks-off at the University of Yaounde